![Christopher Frankenfield](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Christopher Frankenfield
Director of Finance/CFO at
XILIO THERAPEUTICS, INC.
Net worth: 16 947 $ as of 2026-06-29
Profile
Mr. Christopher Frankenfield is a Chief Operating & Financial Officer at Xilio Therapeutics, Inc. Mr. Frankenfield was previously employed as a Vice President-Corporate & Legal Affairs by Blueprint Medicines Corp.
and a Senior Associate by Wilmer Cutler Pickering Hale & Dorr LLP.
He received his undergraduate degree from The College of William & Mary and a graduate degree from the University of Virginia School of Law.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-01-01 | 1,769 ( 0.03% ) | 16 947 $ | 2026-06-29 |
Christopher Frankenfield active positions
| Companies | Position | Start |
|---|---|---|
| XILIO THERAPEUTICS, INC. | Director of Finance/CFO | 2024-08-07 |
Former positions of Christopher Frankenfield
| Companies | Position | End |
|---|---|---|
| BLUEPRINT MEDICINES CORPORATION | General Counsel | 2021-02-28 |
Wilmer Cutler Pickering Hale & Dorr LLP
 Wilmer Cutler Pickering Hale & Dorr LLP Miscellaneous Commercial ServicesCommercial Services Provides legal services | Corporate Officer/Principal | - |
Training of Christopher Frankenfield
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
53
1st degree connections
5
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Wilmer Cutler Pickering Hale & Dorr LLP
Wilmer Cutler Pickering Hale & Dorr LLP Miscellaneous Commercial ServicesCommercial Services Provides legal services | Commercial Services |
The College of William & Mary
 The College of William & Mary Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Blueprint Medicines Corp.
 Blueprint Medicines Corp. BiotechnologyHealth Technology Develops cancer therapies that harness the growing understanding of the molecular blueprint of cancer | Health Technology |
University of Virginia School of Law
 University of Virginia School of Law Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Xilio Therapeutics, Inc.
 Xilio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company which develops tumor-selective immuno-oncology therapies | Health Technology |
- Stock Market
- Insiders
- Christopher Frankenfield
